Funding Opportunity RFA-DK-20-030 from the NIH Guide for Grants and Contracts. Since its establishment in 2006, the Gastroparesis Clinical Research Consortium (GpCRC), a multi-center coalition created and funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has made major advances to our understanding of the pathophysiology of gastroparesis (Gp) and develop an effective treatment for patients with symptomatic gastroparesis. Through the establishment of the largest gastroparesis tissue repository, combined with detailed phenotypic data, the GpCRC is ideally suited to accelerate insights into the underlying cellular and molecular pathophysiology of the gastroparesis with the ultimate goal of developing therapeutic target(s). This RFA invites investigators from several disciplines, including basic and translational research in areas of neurosciences, immunology, microbiology and physiology, to contribute new insights into the cellular and molecular mechanisms of gastroparesis.

Funding Opportunity PAR-21-045 from the NIH Guide for Grants and Contracts. Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)

Competitive Salary: Viapath: Would you like an opportunity to obtain new professional qualifications whilst working in a state-of-the-art laboratory?... London, UK

Competitive Salary: Viapath: Would you like an opportunity to obtain new professional qualifications whilst working in a state-of-the-art laboratory?... London, UK

Funding Opportunity PAR-21-077 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support efficient collection, banking and sharing of biospecimens and associated clinical data from critically ill patients, ultimately for use in mechanistic research on sepsis. The goals of this FOA are to determine the scientific value of existing or newly collected sepsis human biospecimen sets as testbeds for studies on human sepsis, and to provide guidance on the best practices for collecting, utilizing and analyzing human biospecimens, thus maximizing their value for the entire sepsis research community.

Notice NOT-OD-21-023 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-021 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-095 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Web Developer (Open Targets) Location: Cambridge, Cambridgeshire, England

Funding Opportunity RFA-MH-21-112 from the NIH Guide for Grants and Contracts. This SBIR Funding Opportunity Announcement (FOA) is intended to support small businesses to develop and test service-ready, commercially viable tools and technologies for suicide prevention, including technologies that can be used to advance training, quality monitoring, a?nd quality improvement efforts and ultimately improve the availability of evidence-based suicide prevention services. Specifically, this initiative encourages research on the effectiveness-implementation continuum aimed at (1) developing and testing the effectiveness of optimized, service-ready suicide prevention tools for identification, prevention, and treatment of individuals at risk for suicide; and (2) testing strategies to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework. Given the focus on practice-ready accessible resources and products that could be readily integrated into practice, NIMH encourages the use of technology and other design features that make the tools scalable and robust against implementation drift, and a deployment-focused approach that takes into account the perspectives of key stakeholders (e.g., service users, providers, administrators) and system-level factors, such as workforce capacity that influence potential integration of tools into clinical workflows.

Funding Opportunity RFA-MH-21-111 from the NIH Guide for Grants and Contracts. NIMH seeks applications for pilot effectiveness projects to evaluate the preliminary effectiveness of service-ready tools and technologies that can be used to advance training, quality monitoring, and quality improvement efforts and ultimately improve the availability of evidence-based suicide prevention services. Specifically, this initiative encourages research on the effectiveness-implementation continuum aimed at (1) developing and testing the effectiveness of optimized, service-ready suicide prevention tools for identification, prevention, and treatment of individuals at risk for suicide; and (2) testing strategies to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework. Given the focus on practice-ready accessible resources and products that could be readily integrated into practice, NIMH encourages the use of technology and other design features that make the tools scalable and robust against implementation drift, and a deployment-focused? approach that takes into account the perspectives of key stakeholders (e.g., service users, providers, administrators) and system-level factors, such as workforce capacitythat influence potential integration of tools into clinical workflows. This FOA supports pilot effectiveness research to evaluate the feasibility, tolerability, acceptability, safety and preliminary indications of effectiveness of service-ready tools and technologies for suicide prevention and inform the design of definitive effectiveness trials. Support for fully-powered, definitive effectiveness studies focused on service-ready tools and technologies or suicide prevention is provided via the R01 in RFA-MH-21-110. Support for SBIR studies focused on service-ready tools and technologies or suicide prevention is provided via the R4?3?/?R?4?4 in RFA-MH-21-112.

Funding Opportunity RFA-MH-21-110 from the NIH Guide for Grants and Contracts. NIMH seeks applications for research projects to evaluate the effectiveness of service-ready tools and technologies that can be used to advance training, quality monitoring, and quality improvement efforts and ultimately improve the availability of evidence-based suicide prevention services. Specifically, this initiative encourages research on the effectiveness-implementation continuum aimed at (1) developing and testing the effectiveness of optimized, service-ready suicide prevention tools for identification, prevention, and treatment of individuals at risk for suicide; and (2) testing strategies to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework. Given the focus on practice-ready accessible resources and products that could be readily integrated into practice, NIMH encourages the use of technology and other design features that make the tools scalable and robust against implementation drift, and a deployment-focused approach that takes into account the perspectives of key stakeholders (e.g., service users, providers, administrators) and system-level factors, such as workforce capacity that influence potential integration of tools into clinical workflows. This FOA is intended to support effectiveness research of service-ready tools and technologies for suicide prevention that are statistically powered to provide a definitive answer regarding the study tool's effectiveness. Support for pilot effectiveness research to evaluate the initial feasibility, tolerability, acceptability, safety, and preliminary indications of effectiveness of service-ready tools and technologies for suicide prevention is provided via the R34 in RFA-21-111.Support for SBIR studies focused on service-ready tools and technologies or suicide prevention is provided via the R43/R44 in RFA-21-112.

Notice NOT-DA-21-009 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-025 from the NIH Guide for Grants and Contracts

Basic expertise in biology or bioinformatics, such as would be acquired through undergraduate courses. The researcher’s interests include ML techniques in… $13 - $19 an hour
From Indeed - Thu, 12 Nov 2020 17:20:49 GMT - View all Redmond, WA jobs

Notice NOT-DA-20-096 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-020 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-036 from the NIH Guide for Grants and Contracts. NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Notice NOT-NR-20-007 from the NIH Guide for Grants and Contracts